Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05660031 · ClinicalTrials.gov registry record · NA
Treatment of the Biceps With Concomitant Supraspinatus Tears
A NA study of Supraspinatus Tear, sponsored by La Tour Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 4
- Study locations
NCT05660031: Recruiting NA study of Supraspinatus Tear, sponsored by La Tour Hospital.
NCT05660031 is a NA study of Supraspinatus Tear that is actively recruiting participants, run by La Tour Hospital. The registered enrollment target is 180 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05660031, a NA study of Supraspinatus Tear, is actively recruiting participants, sponsored by La Tour Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 4
- Study locations
Study Summary
The long head of the biceps (LHB) tendon is thought to be a common source of shoulder pain and dysfunction in patients with rotator cuff pathology. Tenotomy and tenodesis have been shown to produce favourable and comparable results in treating LHB lesions, but a controversy still exists regarding the treatment of choice. Some suggest that tenotomy should be reserved for older, low-demand patients, while tenodesis should be performed in younger patients and those who engage in heavy labor. Proponents of tenotomy suggest that this is a technically easy procedure that leads to easy rehabilitation and fast return to activity with a low complication and reoperation rate. However, those who support LHB tenodesis list good preservation of elbow flexion and supination strength, improvement of functional scores, elimination of pain, and avoidance of cosmetic deformity as benefits of the procedure. Alternatively, the LHB can be maintained in the joint without tenodesis or tenotomy. In fact, it has not been clearly shown that LHB tenodesis or tenotomy leads to improved outcomes compared to leaving the biceps tendon intact.
Primary Outcome
American Shoulder and Elbow Surgeon (ASES) score. From 0 (worst) to 100 (best).
Conditions Studied
Interventions
- PROCEDURE LHB Tenotomy
- PROCEDURE LHB Tenodesis
Study Locations (4)
Michigan
- Sports Medicine and Shoulder Surgery, University of Michigan - Ann Arbor
Oregon
- Oregon Health & Science University - Portland
Alberta
- Group 23 Sports Medicine - Calgary
Canton of Geneva
- la Tour hospital - Meyrin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2026-06-01 |
| Phase | NA |
What NCT05660031 shows while recruiting
NCT05660031 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Supraspinatus Tear appearing as the primary indexed condition, and to 2 interventions - of which LHB Tenotomy is the first listed.
NCT05660031 reports a single indexed study location in Michigan, Oregon, Alberta.
Frequently Asked Questions
What is clinical trial NCT05660031 about?
NCT05660031 is a clinical study titled "Treatment of the Biceps With Concomitant Supraspinatus Tears". The long head of the biceps (LHB) tendon is thought to be a common source of shoulder pain and dysfunction in patients with rotator cuff pathology. Tenotomy and tenodesis have been shown to produce favourable and comparable results in treating LHB lesions, but a controversy still exists regarding th...
What is the current status of trial NCT05660031?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2021-06-01. Estimated completion is 2026-06-01.
What conditions does trial NCT05660031 study?
This clinical trial studies the following conditions: Supraspinatus Tear.
What interventions are being tested in trial NCT05660031?
The interventions under investigation include: LHB Tenotomy (PROCEDURE), LHB Tenodesis (PROCEDURE).
Who is sponsoring clinical trial NCT05660031?
This trial is sponsored by La Tour Hospital, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05660031 being conducted?
This trial has 4 study locations across Michigan, Oregon, Alberta, Canton of Geneva. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Supraspinatus Tear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05660031's enrollment target sits among peer trials
180 586th of 2000 higher than 1,397 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI